Pharmacyclics is a pharmaceutical company developing innovative
treatments for cancer and other diseases. The company is working on a
range of clinical and laboratory programs and is pursuing the
development of novel drugs aimed at specific disease pathways. The company's most advanced product candidate, Xcytrin®(motexafin gadolinium)
is a rationally designed small molecule, the first in a class of drugs
that concentrates in cancer cells and disr...
more
Pharmacyclics is a pharmaceutical company developing innovative
treatments for cancer and other diseases. The company is working on a
range of clinical and laboratory programs and is pursuing the
development of novel drugs aimed at specific disease pathways. The company's most advanced product candidate, Xcytrin®(motexafin gadolinium)
is a rationally designed small molecule, the first in a class of drugs
that concentrates in cancer cells and disrupts cellular metabolism by a
unique mechanism of action. Xcytrin is in late-stage human clinical
trials for lung cancer and other oncology indications.
less